Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycolate, specifically in the form of the stable isotope-labeled tracer **[1-13C]glycolate**, is used as a metabolic probe to investigate the glyoxylate/oxalate pathway. In clinical research conducted by **Academisch Medisch Centrum (Amsterdam UMC)**, it is administered via continuous primed intravenous infusion to quantify endogenous oxalate production in patients with **primary hyperoxaluria types 1 and 2**. Glycolate is a metabolic precursor to glyoxylate, which is subsequently converted to oxalate; in primary hyperoxaluria type 1, a deficiency in alanine-glyoxylate aminotransferase (AGT) leads to excessive oxalate synthesis from these precursors. This compound serves as a diagnostic and research tool rather than a therapeutic agent, allowing researchers to measure metabolic flux and investigate pyridoxine responsiveness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycolate.